1. CLONAL B‐CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL‐MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS. (12th June 2019) Authors: Kalpadakis, C.; Pangalis, G.A.; Konstantinou, E.; Vassilakopoulos, T.P.; Telonis, V.; Sachanas, S.; Tsirkinidis, P.; Moschogiannis, M.; Yiakoumis, X.; Siakantaris, M.; Tsaftaridis, P.; Iliakis, T.; Befani, M.; Kyrtsonis, M.; Dimitrakopoulou, A.; Boutsikas, G.; Korkolopoulou, P.; Kontopidou, F.; K... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS. (23rd June 2022) Authors: Vassilakopoulos, T.; Piperidou, A.; Mellios, Z.; Verigou, E.; Kalpadakis, C.; Katodritou, E.; Papageorgiou, S.; Chatzidimitriou, C.; Giatra, C.; Leonidopoulou, T.; Xanthopoulos, V.; Karakatsanis, S.; Gainaru, G.; Vrakidou, E.; Koumarianou, A.; Hatzimichael, E.; Verrou, E.; Tsirogianni, M.; Dranda... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT). (12th June 2019) Authors: Vassilakopoulos, T.P.; Papageorgiou, S.G.; Michail, M.; Angelopoulou, M.K.; Kourti, G.; Kalpadakis, C.; Kotsopoulou, M.; Leonidopoulou, T.; Konstantinidou, P.; Kotsianidis, I.; Boutsis, D.; Michali, E.; Sachanas, S.; Terpos, E.; Karianakis, G.; Poziopoulos, C.; Vadikolia, C.; Pigaditou, A.; Vraki... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗